The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 801–900 of 1,810
Maternal immune-mediated conditions and ADHD risk in offspring
Walle, K. M., Gustavson, K., Mjaaland, S., Askeland, R. B., Magnus, P. M., Susser, E., Lipkin, W. I., Stoltenberg, C., Bresnahan, M. A., Reichborn‐Kjennerud, T., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04227-3 · Cited by 10
Obesity and Pregnancy: Impact on Childbirth Timing, Delivery Mode, and Maternal Recovery: An Update
Gerede, A., Danavasi, M., Stavros, S., Potiris, A., Zikopoulos, A., Moustakli, E., Skentou, C., Domali, E., Nikolettos, N., & Eleftheriades, M. I. (2025) · Medical Sciences · doi:10.3390/medsci13030182 · Cited by 25
“Due mainly to complications like preeclampsia and GDM [29], our analysis demonstrates that pregnant women who are obese have significantly higher rates of medically indicated preterm birth (OR 1.5–2.3) [36].”
InfluentialDu, M., Liu, J., Han, N., Zhao, Z., Luo, S., & Wang, H. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108866 · Cited by 5
Development and Fabrication of an Interwoven CuO Nanorod-Based Acetone Sensor With High Selectivity
Karimmirza, E., Yousefizad, M., Manavizadeh, N., Kordmahale, S. B., & Izadi, M. (2024) · IEEE Sensors Journal · doi:10.1109/jsen.2024.3517472 · Cited by 9
Flores-Quijano, M. E., Pérez-Nieves, V., Sámano, R., & Chico‐Barba, G. (2024) · Nutrients · doi:10.3390/nu16244346 · Cited by 10
Borissov, A.-M., Trifonova, B., Dakovska, L., Michaylova, E., & Vukov, M. (2021) · European Journal of Preventive Medicine · doi:10.11648/j.ejpm.20210902.12 · Cited by 5
“For example, overweight and obesity are inextricably linked to systemic, excessive calorie intake, which permanently increases insulin production by β-cells and this adversely affects insulin signaling pathways [14].”
BackgroundLi, S., Jiang, R., Wang, F., Xu, Y., Wang, P., Ma, Y., Pan, J., & Huang, C. X. (2025) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2025.09.001 · Cited by 8
“13 Moreover, women with GDM are at a higher risk of developing type 2 diabetes, and both mothers and their offspring are vulnerable to long-term risk of metabolic disorders and cardiovascular disease 14,15 ; approximately 50 % of women with GDM are anticipated to develop type 2 diabetes within 5…”
Qin, Z., Du, Y., Wang, Z., Qin, X., Wu, H., Yu, X., Zhao, C., Mo, L., & Huang, B. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s480347 · Cited by 9
Mir, R., Elfaki, I., Elnageeb, M. E., Moawadh, M. S., Tayeb, F. J., Barnawi, J., Albalawi, I. A., Alharbi, A. A., Alhelali, M. H., & Alsaedi, B. S. O. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081270 · Cited by 7
“Insulin resistance is accompanied by compensatory insulin release from the pancreatic beta cells, which eventually leads to beta cell exhaustion and dysfunction [7].”
BackgroundAbindu, V., Hope, D., Aleni, M., Andru, M., Ayiasi, R. M., Afayo, V., Oyet, C., & Kiconco, R. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s447855 · Cited by 8
Song, Z., Zhou, Y., Zheng, Y., Huang, W., Meng, Z., Li, H., Jiang, R., Teng, Y., & Tao, M. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14663 · Cited by 6
Wiltgen, A. C., Valentini, N. C., Marcelino, T. B., Guimarães, L. S. P., da Silva, C. H., Bernardi, J. R., & Goldani, M. Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-36626-y · Cited by 5
“Prone1 7 [6; 9] 7 [6; 9] 7 [7; 8] 7 [6; 9] .”
Cao, C., Chen, W., Chen, B., Wang, X., Lu, Y., Zou, X., Kang, X., & Chen, L. (2024) · Biomedical Chromatography · doi:10.1002/bmc.6042 · Cited by 5
Does Second Trimester Maternal Serum Zonulin Level Predict Gestational Diabetes Mellitus?
Tonyalı, N. V., Arslan, B., Sucu, S. T., Sarsmaz, K., İbanoğlu, M. C., Örgül, G., Aktemur, G., Yücel, A., & Şahın, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020394 · Cited by 8
“It is characterized by high blood glucose levels that develop during pregnancy and, if left unchecked, can lead to a number of adverse outcomes for both mother and child, including increased risk of preeclampsia, preterm birth, macrosomia, and neonatal hypoglycemia [2].”
BackgroundInfluentialVentura, E. F., Selma‐Royo, M., Turjeman, S., González, S., Koren, O., & Collado, M. C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.101175 · Cited by 10
Decreased serum human leukocyte antigen‐G levels are associated with gestational diabetes mellitus
Öztekin, Ö., Çabuş, Ü., & Enli, Y. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14811 · Cited by 6
“But this normal mechanism does not properly work and results in GDM in some women.25 Risk factors for development of GDM mainly include obesity, excessive weight gain during pregnancy, genetic polymorphism, western Type diet, advanced maternal age, family or personal history of GDM and PCOS.26 Excessive and prolonged…”
BackgroundCX3CL1 (Fractalkine): An important cytokine in physiological and pathological pregnancies
Hu, X., Huang, X., Yin, T., Chen, J., Zhao, W., Yu, M., Liu, L., & Du, M. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104392 · Cited by 5
Maternal serum sortilin levels in gestational diabetes mellitus
Özalp, M., Akbaş, H., Kızılırmak, R., Albayrak, M., Yaman, H., Akbaş, M., Aran, T., & Osmanagaoglu, M. A. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1972966 · Cited by 5
Alzaim, M., Ansari, M. G. A., Al‐Masri, A. A., Khattak, M. N. K., Alamro, A. A., Alghamdi, A. A., Alenad, A. M. H., Alokail, M. S., Al-Attas, O. S., Al-Zahrani, A. G., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32048 · Cited by 7
Yen, F., Wei, J. C., Wu, Y., Lo, Y., Chen, C., Hwu, C., & Hsu, C. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14288 · Cited by 6
“Currently, the known risk factors of GDM include maternal obesity, multiple pregnancies, a previous history of GDM and a family history of diabetes mellitus 4,5 .”
Gao, J., Song, S., Duo, Y., Wang, S., Qiao, X., Zhang, Y., Xu, J., Zhang, J., Nie, X., Sun, Q., et al. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s538992 · Cited by 6
“LDL-C (2.09 vs 1.98 mmol/ L, p=0.0002), ALT (15.00 vs 12.60 IU/L, p 0.0001), and uric acid (217.00 vs 204.00 μmol/L, p 0.0001) were higher in GDM. LGA incidence was higher in GDM (15.3% vs 8.1%, p 0.001).”
InfluentialFocus on Cell Apoptosis, Pyroptosis and Ferroptosis to Explore Strategic Breakthrough for GDM
Li, J., Fan, L., Yu, N., Wang, M., & Yang, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s524425 · Cited by 7
Liu, L., Zhou, Y., & He, L. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1966764 · Cited by 7
Hashemipour, S., Lalooha, F., Etemad, F. S., & Nozari, F. H. (2022) · Asian Journal of Social Health and Behavior · doi:10.4103/shb.shb_127_22 · Cited by 6
Wang, S., Zhang, Y., Hu, S., Bai, X., Zhu, J., Hao, R., Cao, Y., & Shi, Z. (2025) · The FASEB Journal · doi:10.1096/fj.202402886r · Cited by 7
Versace, V. L., Beks, H., Hannah, W., Namara, K. M., Hague, W. M., Anjana, R. M., Mohan, V., Khunti, K., & Dunbar, J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1727203 · Cited by 6
Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes
Milionis, C., Ilias, Ι., Lekkou, A., Venaki, E., & Koukkou, E. G. (2024) · World Journal of Experimental Medicine · doi:10.5493/wjem.v14.i1.89320 · Cited by 8
Diabetes: A Global Health Concern and Potential Strategies to Reduce Its Prevalence
Tayyab, S. L., Seher, W., Hussain, K., & Murtaza, I. (2024) · Integrated science · doi:10.1007/978-3-031-64288-3_14 · Cited by 7
Pełech, A., Ruszała, M., Niebrzydowska-Tatus, M., Bień, K., Kimber-Trojnar, Ż., Czuba, M., Świstowska, M., & Leszczyńska‐Gorzelak, B. (2023) · Biomolecules · doi:10.3390/biom13040697 · Cited by 5
“Pregnancy is associated with a physiological decrease in the insulin sensitivity of tissues [12,13].”
BackgroundTherapeutic potential of extracellular vesicles for treating human pregnancy disorders
Zheng, S., Georgiou, H. M., Kokkinos, M. I., Colafella, K. M. M., Brennecke, S. P., & Kalionis, B. (2025) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.07 · Cited by 8
Akbari, M. R., Masjedi, F., Nekooeian, M., Dara, M., & Roozbeh, J. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70071 · Cited by 7
“However, in GDM, this resistance becomes excessive, and the pancreas cannot produce suf fi cient insulin to compensate 53,54 .”
Nobre, C. F. A., Capute, V. E. T. B., Cury, N. T., Egger, P. A. L., Azeredo, L. M. L., & de Siqueira, E. C. (2023) · Revista Eletrônica Acervo Médico · doi:10.25248/reamed.e13272.2023 · Cited by 7
Mihiret, G. T., Wondmu, K. S., Baye, F., Minale, M., Yechale, M., Melese, M. F., Haimanot, A. B., & Getaneh, T. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1535344 · Cited by 5
Early Initiation and Long-Term Use of Vaginal Progesterone may Cause Gestational Diabetes Mellitus
Öztekin, D. C., Şenkaya, A. R., Güneş, M. E., Keskin, Ö., & Dogdu, I. A. (2022) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/a-1741-6172 · Cited by 5
Fernandez, L. F., & Pineda-Cortel, M. R. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01479-z · Cited by 5
“This condition has significantly contributed to the vicious, long-standing sequence of obesity and diabetes that impacts the health of the general population [5].”
BackgroundOrós, M., Perejón, D., Serna, M. C., Siscart, J., León, J., Ortega, M., & Salinas‐Roca, B. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02120-5 · Cited by 13
“However, in most cases, hyperglycaemia is the result of impaired glucose tolerance either due to dysfunction of pancreatic β cells, or to defects in the insulin signalling cascade that causes chronic insulin resistance [15, 16].”
BackgroundLim, S. S., Takele, W. W., Vesco, K. K., Redman, L. M., ADA PMDI GDM prevention working group, & Josefson, J. L. (2023) · medRxiv · doi:10.1101/2023.04.16.23288650 · Cited by 5
“Prevention of GDM involves reducing hyperglycemia and insulin resistance, factors that are also highly correlated with obesity (10, 11).”
BackgroundNaz, M. S. G., Sheidaei, A., Azizi, F., & Tehrani, F. R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108311 · Cited by 5
Gestational Diabetes: A Review
Barbach, A., Chenguiti, A. A., Charrah, Y., & Barkat, A. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2649 · Cited by 7
Leirós‐Rodríguez, R., & Rodríguez-Martínez, C. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210820110941 · Cited by 8
Li, X., Cai, Q., Luo, X., Wang, Y., Shao, L., Luo, S., Wang, L., Wang, Y., Lan, X., & Liu, T. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01294-z · Cited by 5
“GDM may be explained for the increased risk of pregnancy complications such as pre-eclampsia, preterm labour, and excessive growth of the fetus [3, 8].”
BackgroundPrüst, J. T., Brummaier, T., Wah, M., Yee, H. H., Win, N. N., Pimanpanarak, M., Min, A. M., Gilder, M. E., Tun, N. W., Ilozumba, O., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17743.1 · Cited by 8
Basu, J., Mukherjee, R., Sahu, P., Datta, C., Chowdhury, S., Mandal, D., & Ghosh, A. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2248201 · Cited by 5
“[14,15] Actually, in β-cells, proinsulin undergoes proteolytic cleavage by prohormone convertases (PC1, PC2) to form mature insulin and C-peptide that are secreted in equimolar amounts; for this, C-peptide is often used as a measure of endogenous insulin.”
BackgroundKoerner, R., Groer, M. E., & Prescott, S. M. (2022) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2022.06.037 · Cited by 7
Mahindra, M. P., Jie, M., Mapindra, M. P., Rehman, S., Vaughan, O. R., Hillman, S. L., David, A. L., & Siassakos, D. M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08016-x · Cited by 9
“As part of normal physiological metabolic adaptation in pregnancy, increased maternal insulin resistance, lipolysis, and hepatic gluconeogenesis alongside reduced skeletal muscle glucose uptake is aimed for maintaining maternal glucose availability for the fetus [1–3].”
Widowati, W., Tjokropranoto, R., Wahyudianingsih, R., Tih, F., Sadeli, L., Kusuma, H. S. W., Fuad, N. A., Girsang, E., & Agatha, F. A. (2021) · Journal of Reports in Pharmaceutical Sciences · doi:10.4103/jrptps.jrptps_3_21 · Cited by 13
Gao, M., Wang, H., Li, W., Wang, L., Li, N., Qiao, Y., Zhang, T., Li, J., Yu, Z., Hu, G., et al. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12995 · Cited by 6
“First, under the circumstance of increased insulin resistance and decreased β-cell function, maternal excessive glucose, amino acids and fatty acids can pass across the placental barrier and stimulate foetus to secrete excessive insulin and insulin-like growth factor 1.(33) They can lead to accumulation of adipose tis…”
BackgroundYap, P. P. H., Nadal, I. P., Rysinova, V., Basri, N. I., Samsudin, I. N., Forbes, A., Noor, N. M., Supian, Z. A., Hassan, H., Paimin, F., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052554 · Cited by 6
Gestational Vitamin E Status and Gestational Diabetes Mellitus: A Retrospective Cohort Study
Shi, H., Gong, X., Sheng, Q., Li, X., Wang, Y., Wu, T., Zhao, Y., & Wei, Y. (2023) · Nutrients · doi:10.3390/nu15071598 · Cited by 6
Antepartum Fetal Surveillance and Optimal Timing of Delivery in Diabetic Women: A Narrative Review
Braverman-Poyastro, A., Suárez-Rico, B. V., Borboa-Olivares, H. J., y Sosa, S. E., Torres‐Torres, J., Arce-Sánchez, L., Martínez-Cruz, N., & Reyes-Muñoz, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020313 · Cited by 7
“Insulin resistance (IR) and relative pancreatic β -cell dysfunction are central features of GDM [1,16,17].”
BackgroundEarly‐life menstrual characteristics and gestational diabetes in a large US cohort
Wang, Z., Baird, D. D., Williams, M. A., Jukic, A. M. Z., Wilcox, A. J., Curry, C. L., Fischer‐Colbrie, T., Onnela, J.-P. “., Hauser, R. B., Coull, B. A., et al. (2024) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.13129 · Cited by 8
“54,55 Fourth, we did not collect information such as GDM subtype or glucose measurements for past pregnancy history.”
Bai, X., Zhu, Q., Wang, W., Kan, S., Hu, S., Hao, R., Wang, S., & Shi, Z. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14269 · Cited by 10
“These are of great concern, particularly given the increased lifetime risk of metabolic disorders and cardiovascular events 38 .”
BackgroundÖzyıldırım, S., Barman, H. A., Doğan, Ö. T., et al. (2023) · Medicina · doi:10.3390/medicina59101811 · Cited by 5
“Furthermore, the reduced CFR among GDM patients signifies a possible connection between gestational hyperglycemia and impaired coronary microvascular function [29].”
BackgroundYuan, C. K., Gao, Y., Yu, J., & Peng, L. (2024) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00505-4 · Cited by 6
“Gestational diabetes mellitus (GDM) is a hyperglycemic condition in pregnant women, the symptoms of which are metabolic alterations, gestational hypertension, and insulin resistance (Plows et al. 2018).”
InfluentialCognitive Impairment Induced by Gestational Diabetes: The Role of Oxidative Stress
Campo-Rota, I. M. D., Delgado-Casillas, O. M., & Ibarra, A. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103016 · Cited by 6
Milan, K. L., Jayasuriya, R., Harithpriya, K., Anuradha, M., & Ramkumar, K. M. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.104143 · Cited by 5
Relationship between life’s essential 8 and the risk of gestational diabetes among us adults
Qin, L., Fan, Z., Shi, Q., Hu, H., Ma, F., Huang, Y., & Tan, F. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2407037 · Cited by 5
“Obesity was reported to affect GDM through several possible mechanisms, including impaired β-cell function, insulin resistance, and chronic low-grade inflammation [33,34].”
Chen, Y., Ye, X., Wu, H., Yuan, X., Yu, X., Wu, H., Wu, X., & Chen, Y. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060245 · Cited by 5
Mommy’s microbes: Gestational diabetes mellitus shapes the maternal and infant gut microbiome
Aja, E., & Jacobs, J. P. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.007 · Cited by 5
Pineda-Cortel, M. R., Baybayan, K., Bello, P. L., Camenforte, L. L., Ching, S. J., Conti, K., Ignacio, J. J., Diaz, J., Villavieja, A., Pandac, J. K., et al. (2021) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.321123 · Cited by 4
Zhuang, M., Wang, B., Shi, Y., & Zhou, Z. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.008 · Cited by 11
Diabetes in Pregnancy: Preconception to Postpartum
Healy, A. M. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.009 · Cited by 6
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis
Tiong, P., Kosmider, L., Lassi, Z. S., Arstall, M. A., & Andraweera, P. H. (2022) · Endocrine · doi:10.1007/s12020-022-03260-z · Cited by 4
“high degree of insulin resistance and vascular endothelial injury in affected women [1].”
BackgroundInfluentialJiang, Y., Du, Y., Su, R., Wei, L., Gao, P., Zhang, J., Zhou, X., Zhu, S., Zhang, H., Chen, Y., et al. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231199077 · Cited by 4
“Among the participants, 14 women were diagnosed with GDM, while the remaining 14 women had uncomplicated pregnancies.”
BackgroundInfluentialChahed, S., Lassouad, L., Dardouri, M., Mtiraoui, A., Maaroufi, A., & Khaïri, H. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.43.128.34084 · Cited by 17
“The oral glucose tolerance test was used from 24 to 28 weeks for GDM screening in patients without any risk factors, such as advanced maternal age (≥35 years) [20], overweight or obesity, personal and family history of any form of diabetes [21].”
MethodHyperglycaemia in pregnancy: Outcomes and diagnostic accuracy of combined modalities
Manga, J., Odell, N., Khambule, L., Harishun, S., & Mohamed, F. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100495 · Cited by 6
Association of leukocyte counts in the first trimester with glucose intolerance during pregnancy
Wang, L., Li, W., Zhang, S., Liu, H., Li, W., Hu, T., & Leng, J. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13633 · Cited by 4
Gestational diabetes mellitus management: diet and lifestyle
Allehdan, S., Basha, A. S., & Tayyem, R. (2020) · Nutrition & Food Science · doi:10.1108/nfs-03-2020-0095 · Cited by 5
Insights to the emerging potential of glucokinase activators as antidiabetic agent
Mehra, A., Kumar, S., Mittal, A., Kohli, R., & Mittal, A. (2024) · Pharmaceutical Patent Analyst · doi:10.1080/20468954.2024.2389762 · Cited by 5
Ding, Y., Zheng, X., Liu, Y., Wei, T., Yue, T., Wang, S., Chen, S., Weng, J., & Luo, S. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002423 · Cited by 6
“Usually, following the delivery of the placenta, which is the main source of diabetogenic hormones, insulin sensitivity is restored, and glucose intolerance is resolved.([20]) Emerging evidence suggests that women who develop GDM already have b-cell dysfunction and chronic insulin resistance long before pregnancy, whi…”
BackgroundCausal Associations Between Sarcopenia and Gestational Diabetes Mellitus
Huang, Y., Zhao, S., Hong, J., Shen, L., Wang, Z., & Wang, D. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s494910 · Cited by 6
“…on sarcopenia and diabetes, our study confirmed that sarcopenia plays a role in the development of GDM. Sarcopenia can disrupt glucose metabolism and lead to insulin resistance, 27 elevating the risk of GDM. 28 Muscle tissue contributes to the regulation of inflammation and metabolism in the body.”
InfluentialMelatonin Administration Prevents Placental and Fetal Changes Induced by Gestational Diabetes
de Melo, I. M. F., Ferreira, C. G. M., Alves, É. R., D’assunção, C. G., Neto, C. J. C. L., de Albuquerque, Y. M. L., Teixeira, V. W., & Teixeira, Á. A. C. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00850-0 · Cited by 5
Preston, E. V., Lytel-Sternberg, J., Quinn, M. R., Williams, P. L., Seely, E. W., Brown, F. M., Hacker, M. R., McElrath, T. F., Cantonwine, D. E., Wylie, B. J., et al. (2025) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2025.114569 · Cited by 5
Yavuz, A., Kocaöz, S., Kara, P., & Destegül, E. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2152657 · Cited by 4
“Although prevalence varies according to the population and diagnostic criteria (Johns et al. 2018), it is estimated that 14% of pregnant women are affected by GDM – according to the 2017 data of the International Diabetes Federation (Plows et al. 2018).”
BackgroundWang, X., He, Z., Ji, J., Zhang, S., Li, J., Zhang, J., Yu, W., Yang, H., Han, Z., Mi, Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04281-x · Cited by 4
“Despite standardized diagnostic criteria, GDM represents a heterogeneous disorder [5] with variable pathophysiology [6].”
Alenezi, H. N., Alanazi, F. K., Muhanna, A. I. B., Softa, S. M., Alsel, B. T. A., Bayomy, H. E.-S., Esmaeel, S. E., & Fawzy, M. S. (2025) · Women · doi:10.3390/women5030029 · Cited by 7
“These hormonal changes induce progressive insulin resistance, a normal physiological adaptation in pregnancy intended to ensure adequate nutrient supply to the fetus [4].”
Anthony, N., Ahmad, A., Bibi, C., Amirzadah, W., Humayun, S., Sajid, M., Ashraf, Z., Abid, M., Khan, M. H., & Yousafzai, Z. A. (2021) · Cureus · doi:10.7759/cureus.17424 · Cited by 5
“, obesity with a BMI above 30kg/m2, high blood sugar, bad cholesterol, hypertension, smoking, lack of exercise, personal history of GDM, and family history of diabetes [1-6].”
BackgroundPan, K., Jukic, A. M. Z., Mishra, G. D., Mumford, S. L., Wise, L. A., Schisterman, E. F., Ley, S. H., Charlton, B. M., Chavarro, J. E., Hart, J. E., et al. (2023) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.13008 · Cited by 5
LncRNA HCG27 Promotes Glucose Uptake Ability of HUVECs by MiR-378a-3p/MAPK1 Pathway
Zhang, J., Jiang, Y., Wei, L., Zhou, X., Zhu, S., Zhang, H., Chen, Y., Gao, P., Yu, J., Wang, S., et al. (2023) · Current Medical Science · doi:10.1007/s11596-023-2738-1 · Cited by 5
Erbetta, K. F., Almeida, J., & Thomas, K. A. (2023) · Women s Health Issues · doi:10.1016/j.whi.2023.06.007 · Cited by 4
Ganho ponderal e estado nutricional de mulheres portadoras de diabetes mellitus gestacional
Neris, V. A., da Silva, T. V. N., Albuquerque, M. N. D. L., Augusto, F. D. R., Gomes, A. C. B., da Silva, S. A., Maio, R., & Burgos, M. G. P. D. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i3.13565 · Cited by 5
Siemers, K. M., Joss‐Moore, L. A., & Baack, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111534 · Cited by 6
“Gestational diabetes mellitus (GDM) is caused by excessive insulin resistance during pregnancy, resulting in increased levels of circulating glucose and lipids in the parent [1].”
BackgroundRawi, H. Z., Nori, W., Salman, D. A., Issa, A. H., & Akram, W. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5112262 · Cited by 5
Wang, M., Chen, X., Shang, Y., Chen, B., Chen, H., Zhou, L., Li, H., Zhang, D., Tao, B., Zhou, X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116775 · Cited by 4
Glycemic control in gestational diabetes and impact on biomarkers in women and infants
Hofer, O. J., Alsweiler, J. M., Tran, T. D., & Crowther, C. A. (2023) · Pediatric Research · doi:10.1038/s41390-022-02459-0 · Cited by 5
“The extent of the reduction in adiponectin during pregnancy results in fetal overgrowth and correlates with the risk of having a large-for-gestational-age (LGA) infant.(3,9) Whether infants born to women with GDM have an altered cord adipokine and cytokine profile remains unclear, with data limited to small case–contr…”
BackgroundResultAchievements in the Pathophysiology and Treatment of Insulin Resistance: Every Step Matters
Dimitriadis, G. (2025) · Nutrients · doi:10.3390/nu17071223 · Cited by 5
“Weight gain during pregnancy signifies maternal fat accumulation, a vital aspect of fetal growth and healthy pregnancy progression [22].”
Chen, G., Wu, L., Ji, C., Xia, J., & Liu, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1554840 · Cited by 9
Primal, D., Putri, T. A., & Meiriza, W. (2021) · Jurnal Keperawatan Silampari · doi:10.31539/jks.v4i2.1876 · Cited by 4
“%) dimana karbohidrat harian secara signifikan berhubungan dengan nilai glukosa postprandial dan respon insulin selama kehamilan (Hasbullah et al., 2020; Rasmussen et al., 2020).”
BackgroundInfluentialMalhotra, R., Jakhar, B., Bisht, K., Kant, R., Singh, A. K., Khoiwal, K., & Singh, B. B. (2022) · Cureus · doi:10.7759/cureus.33008 · Cited by 4
“Gestational diabetes mellitus (GDM), as described by the American Diabetes Association, is a condition of elevated blood glucose level, detected for the first time in mid or third trimester of pregnancy, without any known cause [11-14].”
BackgroundKeser, M. K., Şahin, D., & Yalçın, S. S. (2024) · Nutrients · doi:10.3390/nu16244334 · Cited by 7
“Mechanistically, GDM arises from impaired pancreatic cell function, particularly in the second and third trimesters, often culminating in insulin resistance mediated by proinflammatory cytokines [8].”
Current status of Liraglutide delivery systems for the management of type 2 diabetes mellitus
Chatterjee, R., Galave, V. S. B., & Jindal, A. B. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01965-y · Cited by 7
Azeez, T. A., Briggs, T. A., & Adeyanju, A. S. (2023) · The New Indian Journal of OBGYN · doi:10.21276/obgyn.2023.9.2.2 · Cited by 4
Zhāng, P., Lappen, J. R., Attaway, A. H., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.12.013 · Cited by 4
Abirami, P. M., Milan, K. L., Anuradha, M., & Ramkumar, K. M. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11373-6 · Cited by 3
“The pathogenesis of GDM is multifaceted, involving complex interactions involving an interplay of genetic predisposition, metabolic dysregulation, and environmental influences [3].”
Xiang, Y., Zhang, S., Li, Y., Dong, W., Luo, Q., & Lei, X. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1573470 · Cited by 5
Lingaiah, S., Vääräsmäki, M., Öhman, H., Kajantie, E., Keikkala, E., & Mustaniemi, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01843-0 · Cited by 6
“Thus, the number of abnormal values in the OGTT can reflect the severity of GDM. Normal pregnancy is characterized by physiological insulin resistance with a compensatory increase in insulin secretion [15].”
Kumar, S. N., Suseela, T. L., Parveen, S., Neeraja, S. R. K., Vaishnavi, R., Jyothi, S., & Ganesh, R. S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112256 · Cited by 9
Bukasa, L., Cortina‐Borja, M., Peters, H., Taylor, G. P., & Thorne, C. (2023) · Journal of the International AIDS Society · doi:10.1002/jia2.26078 · Cited by 5
“Pregnancy is a physiological state of reduced insulin sensitivity [2] and GD is thought to result from complex mechanisms involving beta-cell dysfunction influenced by genetic, epigenetic and environmental factors [3].”
BackgroundGestational diabetes and mental health: longitudinal analysis of data from the GEMS randomized trial
Ohene‐Agyei, P., Gamble, G. D., Tran, T. D., Harding, J. E., & Crowther, C. A. (2025) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01551-0 · Cited by 5
“…(World Health Organization 1999), is the commonest metabolic disorder in pregnancy, and is associated with adverse outcomes including maternal pre-eclampsia (Plows et al. 2018), induced labour (Plows et al. 2018 ; Shen et al. 2020), and birth of a large-for-gestational age baby (Plows et al. 2018).”
Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes
Asadi, P., Vessal, M., Khorsand, M., & Takhshid, M. A. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00464-5 · Cited by 4
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.